Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 01 November 2020
Author/s

author: Laurence Albiges  Howard Gurney  Camillo Porta 

Publication date November 1, 2020
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item